EPIC Alliance Discusses MR Conditional Devices and Best Practices at Europace-Cardiostim 2017
International, All-Woman Faculty Deliberates Clinical Workflow at Scientific Symposium
The recent technological breakthrough in MR conditional devices means patients can access crucial MRI scans. “Events like this symposium are vital,” explained EPIC Alliance steering committee member Dr. Jeanne Poole, University of Washington, Seattle, US. “There should be a continuous interchange on best practices before and after MRI scans. It’s important to have excellent collaboration between radiologists and cardiologists, and all parties need to be informed of options to ease workflow.”
Possibilities to streamline physician workflow include BIOTRONIK’s award-winning MRI AutoDetect feature, which enables the device to automatically recognize when it is in an MRI environment. Meanwhile, the online tool ProMRI® Check allows physicians to check the MR conditionality of BIOTRONIK systems.
The symposium featured the presentations:
- “Cardiac MRI to Determine LV Lead Positioning, Worth the Effort?” by Dr. Yong-Mei Cha, Mayo Clinic, Rochester, Minnesota, US
- “Extracting Abandoned Leads: Is a Need for an MRI Scan a Good Enough Reason?” by Dr. Ulrika Birgersdotter-Green, University of California San Diego, California, US
- “How Do We Manage Our Patients with Non-MR Conditional Devices?” by Dr. Marye Gleva, Washington University, Saint Louis, Missouri, US
- “MRI Scanning: Establishing a Practical and Safe System in Your Hospital” by Dr. Andrea Russo, Cooper University Hospital, Camden, New Jersey, US
About the EPIC Alliance
The Electrophysiologist International Community (EPIC) Alliance is a global network of over 200 women EPs and cardiac device specialists. Founded in 2010, its aims to diversify the medical field by promoting women in their professional and personal lives. The alliance fosters peer support, clinical research opportunities, and career development to help women gain leadership positons in their clinics, professional associations and at scientific congresses. BIOTRONIK sponsors EPIC with an educational grant. Register to receive news about upcoming events and scientific sessions.
A global leader in cardio- and endovascular medical technology, BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries. Several million patients have received BIOTRONIK implants designed to save and improve the quality of their lives, or have been treated with BIOTRONIK coronary and peripheral vascular intervention products. Since its development of the first German pacemaker in 1963, BIOTRONIK has engineered many innovations, including Magmaris, the first clinically-proven resorbable magnesium scaffold; BIOTRONIK Home Monitoring®; Pulsar, the world's first 4 F compatible stent for treating long lesions; Orsiro, the industry's first hybrid drug-eluting stent; and the world's first implantable cardioverter defibrillators and heart failure therapy devices with ProMRI® technology.
For more information, visit: www.biotronik.com